GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (LTS:0R44) » Definitions » Median PS Value

C-Rad AB (LTS:0R44) Median PS Value : kr75.74 (As of May. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is C-Rad AB Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. C-Rad AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr13.57. C-Rad AB's 10-Year median PS Ratio is 5.5814. Therefore, the Median PS Value for today is kr75.74.

As of today (2024-05-28), C-Rad AB's share price is kr41.90. C-Rad AB's Median PS Value is kr75.74. Therefore, C-Rad AB's Price to Median PS Value for today is 0.55.

The historical rank and industry rank for C-Rad AB's Median PS Value or its related term are showing as below:

LTS:0R44' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44   Med: 0.68   Max: 1.3
Current: 0.55

During the past 13 years, the highest Price to Median PS Value of C-Rad AB was 1.30. The lowest was 0.44. And the median was 0.68.

LTS:0R44's Price-to-Median-PS-Value is ranked better than
71.79% of 319 companies
in the Medical Devices & Instruments industry
Industry Median: 0.8 vs LTS:0R44: 0.55

C-Rad AB Median PS Value Historical Data

The historical data trend for C-Rad AB's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Median PS Value Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.12 35.46 43.79 51.28 71.15

C-Rad AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.88 58.62 64.42 71.15 74.59

Competitive Comparison of C-Rad AB's Median PS Value

For the Medical Devices subindustry, C-Rad AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Price-to-Median-PS-Value falls into.



C-Rad AB Median PS Value Calculation

C-Rad AB's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=13.57*5.5814
=75.74

10-Year Median PS Ratio is 5.5814.
C-Rad AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Rad AB  (LTS:0R44) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

C-Rad AB's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=41.90/75.74
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Rad AB Median PS Value Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB (LTS:0R44) Business Description

Traded in Other Exchanges
Address
Sjukhusvägen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (LTS:0R44) Headlines

No Headlines